Theme
Biotech '24: Pharma/Therapeutics☆
ALT-35.00%7.7%
ARQT+18.25%7.7%
ARWR+68.44%7.7%
AVXL-83.82%7.7%
BCRX+14.34%7.7%
BHVN-30.76%7.7%
HALO+68.70%7.7%
KNSA+106.64%7.7%
KROS-27.79%7.7%
KYMR+91.69%7.7%
SPRY-60.62%7.7%
TERN-2.82%7.7%
VRDN-15.91%7.7%
As of Oct 9, 2026, 4:27 AM ET
Biotech '24: Pharma/Therapeutics Constituents
Altimmune, Inc.ALT | 7.7% | -2.26% | -12.16% | -22.39% | -5.80% | -27.98% | -39.68% | -45.61% | -35.00% | -58.33% | -78.64% | $505.6M |
Anavex Life Sciences Corp.AVXL | 7.7% | 0.65% | -34.47% | -44.00% | -18.52% | -56.74% | -65.24% | -82.01% | -83.82% | -70.61% | -91.06% | $142.7M |
Arcutis Biotherapeutics, Inc.ARQT | 7.7% | 1.32% | -10.39% | 2.73% | -3.16% | -15.67% | -9.20% | 47.53% | 18.25% | 153.00% | 9.62% | $3.06B |
Arrowhead Pharmaceuticals, Inc.ARWR | 7.7% | -1.20% | -7.21% | -26.49% | -6.25% | -8.51% | -4.00% | 378.64% | 68.44% | 237.07% | 0.68% | $8.56B |
ARS Pharmaceuticals, Inc.SPRY | 7.7% | 4.59% | 10.41% | -12.81% | 10.68% | -60.86% | -50.86% | -65.06% | -60.62% | -67.15% | -52.70% | $452.8M |
BioCryst Pharmaceuticals, Inc.BCRX | 7.7% | -1.31% | -2.13% | -5.90% | 2.09% | 6.28% | -5.26% | 11.57% | 14.34% | 15.14% | -42.67% | $2.11B |
Biohaven Ltd.BHVN | 7.7% | 0.42% | -10.10% | -20.47% | -9.21% | 5.67% | 3.56% | -49.62% | -30.76% | -77.72% | 63.42% | $1.80B |
Halozyme Therapeutics, Inc.HALO | 7.7% | -0.86% | -2.70% | 2.28% | 2.71% | 63.21% | 57.97% | 74.29% | 68.70% | 102.92% | 193.22% | $13.03B |
Keros Therapeutics, Inc.KROS | 7.7% | 3.84% | 3.19% | 2.92% | 3.37% | -42.83% | -17.97% | 15.94% | -27.79% | -80.49% | -68.50% | $230.8M |
Kiniksa Pharmaceuticals International, plcKNSA | 7.7% | 1.01% | 3.48% | 0.29% | 4.69% | 90.91% | 77.01% | 260.41% | 106.64% | 221.82% | 603.75% | $6.00B |
Kymera Therapeutics, Inc.KYMR | 7.7% | 0.88% | -2.41% | -5.31% | -0.74% | 40.47% | 19.65% | 314.64% | 91.69% | 153.95% | 96.58% | $8.99B |
Terns Pharmaceuticals, Inc.TERN | 7.7% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 231.73% | -2.82% | 5.76% | -19.88% | $744.0M |
Viridian Therapeutics, Inc.VRDN | 7.7% | 0.33% | -10.84% | -19.31% | -3.42% | -41.07% | -37.58% | 40.32% | -15.91% | -21.62% | 13.21% | $2.08B |
| Theme return | — | 0.57% | -5.79% | -13.26% | -2.38% | -4.46% | -6.64% | 59.86% | 6.07% | 29.79% | 112.13% | — |
| Average | 7.7% | 0.57% | -5.79% | -11.42% | -1.81% | -3.62% | -5.51% | 87.14% | 8.56% | 39.52% | 48.23% | $3.67B |
| Median | 7.7% | 0.42% | -2.70% | -5.90% | -0.74% | -8.51% | -5.26% | 40.32% | -2.82% | 5.76% | 0.68% | $2.08B |
| Std Dev | 0.0% | 1.86% | 10.48% | 13.82% | 7.01% | 44.15% | 38.81% | 149.48% | 57.29% | 114.00% | 177.46% | $3.99B |
| Min | 7.7% | -2.26% | -34.47% | -44.00% | -18.52% | -60.86% | -65.24% | -82.01% | -83.82% | -80.49% | -91.06% | $142.7M |
| Max | 7.7% | 4.59% | 10.41% | 2.92% | 10.68% | 90.91% | 77.01% | 378.64% | 106.64% | 237.07% | 603.75% | $13.03B |
| % Positive Tickers | 61.54% | 23.08% | 30.77% | 38.46% | 38.46% | 30.77% | 69.23% | 46.15% | 53.85% | 53.85% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort